In this study, 249 mice who were identified with SCC tumors received treatment with a range of drug regimens. 
Over the course of 45 days, tumor development was observed and measured. The purpose of this study was to compare the performance of Pymaceuticalsâ€™ 
drug of interest, Capomulin, against the other treatment regimens.
Further info can be found in the 'pymaceuticals.ipynb' file
